Assessment of Patient Perspectives and Barriers to Self-Infusion of Augmentation Therapy for Alpha-1 Antitrypsin Deficiency During the COVID-19 Pandemic

INTRODUCTION: Alpha-1 antitrypsin (AAT) deficiency is an autosomal co-dominant genetic condition that predisposes individuals to pulmonary and hepatic disease, and in severe cases is treated with augmentation by intravenous infusion. Our aim was to assess patient reluctance to transition to self-adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Colello, Jacob, Ptasinski, Anna, Zhan, Xiang, Kaur, Sundeep, Craig, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784277/
https://www.ncbi.nlm.nih.gov/pubmed/35067906
http://dx.doi.org/10.1007/s41030-022-00182-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784277/
https://www.ncbi.nlm.nih.gov/pubmed/35067906
http://dx.doi.org/10.1007/s41030-022-00182-z

Ejemplares similares